Shares of Citius Pharmaceuticals, a developer of drugs for bloodstream infections, lymphoma, and hemorrhoids, surged over 10% on Wednesday, July 10. This came after the company announced that it had completed trials of one of its drugs and is close to commercially launching another. The company expects “strong momentum” if…